Zhang, Wenbin
Zhou, Qinyi
Zhang, Jun https://orcid.org/0000-0001-5521-2092
Wang, Jiachen
Wu, Qingcui
Zheng, Sanduo https://orcid.org/0000-0002-7784-0177
Wang, Xiaodong https://orcid.org/0000-0001-9885-356X
Funding for this research was provided by:
Chinese Ministry of Science and Technology | Department of S and T for Social Development (n/a)
Chinese Ministry of Science and Technology | Department of S and T for Social Development (n/a)
Chinese Ministry of Science and Technology | Department of S and T for Social Development (n/a)
Chinese Ministry of Science and Technology | Department of S and T for Social Development (n/a)
Chinese Ministry of Science and Technology | Department of S and T for Social Development (n/a)
Chinese Ministry of Science and Technology | Department of S and T for Social Development (n/a)
Article History
Received: 2 December 2024
Accepted: 24 July 2025
First Online: 22 August 2025
Competing interests
: X.W. is a cofounder and consultant of Sironax, a biotech startup working on developing therapeutic agents against neurodegenerative diseases. X.W. owns 5.5% of the Sironax stock. The remaining authors declare no competing interests.